Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Primary Cutaneous Anaplastic Large Cell × Bexarotene × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Mycosis Fungoides 2 Sezary Syndrome 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Methotrexate 1 Brentuximab Vedotin 1 Bexarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01578499 2021-01-05

ALCANZA

Takeda

Phase 3 Completed

131 enrolled 24 charts

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphoma, Primary Cutaneous Anaplastic Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡